Skip to main content

Sovran Advisors, LLC

SEC CIK
0002051471
Latest filing
Jul 29, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Sovran Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
516
Value
$358.7K
% of portfolio
<0.1%
Quarters held
5
Since Q2 2025
Holdings of REGN by Sovran Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026516$358.7K<0.1%−5,503−91.4%ReducedHolders
Q1 20266,019$4.26M0.3%−2,600−30.2%ReducedHolders
Q4 20258,619$6.39M0.5%−2,519−22.6%ReducedHolders
Q3 202511,138$7.28M0.6%+6,118+121.9%AddedHolders
Q2 20255,020$2.75M0.3%+5,020NewHolders